Mostrar el registro sencillo del ítem
dc.contributor.author | Díaz Soto, Gonzalo | |
dc.contributor.author | Pérez López, Paloma | |
dc.contributor.author | Fernández Velasco, Pablo | |
dc.contributor.author | Bahillo Curieses, María del Pilar | |
dc.contributor.author | Nieto de la Marca, María de la O | |
dc.contributor.author | Jimenez, Rebeca | |
dc.contributor.author | Luis Román, Daniel Antonio de | |
dc.date.accessioned | 2025-02-27T13:50:29Z | |
dc.date.available | 2025-02-27T13:50:29Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Endocrine, 2024, vol. 86, n. 1, p. 186-193 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/75180 | |
dc.description | Producción Científica | es |
dc.description.abstract | Introduction To evaluate the relationship between the GRI -component of hypoglycemia (CHypo) and hyperglycemia (CHyper)- with diabetes quality of life (DQoL), diabetes-related stress (DDS), perception of hypoglycemia (Clarke Test), visual analogic scale (VAS) and diabetes-knowledge (DKQ2) in T1D. Methods Cross-sectional study in 92 patients with T1D under intensive insulin treatment (21.7% CSII) and flash glucose monitoring (isCGM). Clinical, metabolic and glycometric parameters and quality of life/satisfaction questionnaires were analyzed. Results 92 patients (54.3% male, BMI 25.4 ± 4.5 kg/m 2 , HbA1c 7.5 ± 1.0%, TIR 53.9 ± 15.9%) with mean age 36.1 ± 12.6years and 17.8 ± 11.3 T1D duration. The mean GRI was 60.6 ± 22.2 with a CHypo and CHyper of 5.9 ± 4.8 and 27.3 ± 14.4, respectively. 19.1% presented a pathological Clarke’s test. Patients with TIR > 70% and GRI < 40 showed better VAS (8.8 ± 1.3 vs 9.3 ± 0.9, p < 0.05) and DDS (46.4 ± 22.1 vs 36.7 ± 16.6, p < 0.05) scores, showing no differences between groups. CHyper > 15 and Chypo > 3.4 were related to worse levels of DQoL (91.1 ± 23.9 vs 76.6 ± 18.6 and 94.6 ± 24.8 vs 79.8 ± 20.1, p < 0.01), DDS(49.8 ± 22.4 vs 35.7 ± 16.5 and 49.8 ± 22.4 vs 35.7 ± 16.5, p < 0.01),and DKQ2 (24.4 ± 4.3 vs 26.8 ± 5.2 and 24.1 ± 4.8 vs 26.0 ± 4.6, p < 0.05), respectively. Worse metabolic control defined by GRI correlated with worse scores in VAS (r = −0.209, p < 0.05), DQoL (r = 0.205, p < 0.05), and DDS (r = 0.205, p < 0.05). No difference was observed in knowledge´s scale. CHyper correlated with worse scores in VAS (r = −0.231, p < 0.05), DQoL (r = 0.422, p < 0.01), and DDS (r = 0.341, p < 0.01) and lower degree of knowledge DKQ2 (r = −0.231, p < 0.05). When analyzing DQoL as a dependent variable in a multiple lineal regression, only age (β = 0.747; p < 0.001) and CHyper (β = 0.717; p < 0.001) maintained statistical significance. Conclusions Higher GRI was related to worse quality of life, diabetes-related stress and satisfaction with treatment, analogous to the TIR results.CHyper an Chypo were related to a greater decline in quality of life, diabetes-related stress, and lower satisfaction with treatment.However, in a multiple linear regression, only CHyper maintained statistical significance. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Springer | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.classification | GRI | es |
dc.subject.classification | Quality of life | es |
dc.subject.classification | Diabetes related stress | es |
dc.subject.classification | TIR | es |
dc.title | Quality of life, diabetes-related stress and treatment satisfaction are correlated with glycemia risk index (GRI), time in range and hypoglycemia/hyperglycemia components in type 1 diabetes | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2024 The Author(s) | es |
dc.identifier.doi | 10.1007/s12020-024-03846-9 | es |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s12020-024-03846-9 | es |
dc.identifier.publicationfirstpage | 186 | es |
dc.identifier.publicationissue | 1 | es |
dc.identifier.publicationlastpage | 193 | es |
dc.identifier.publicationtitle | Endocrine | es |
dc.identifier.publicationvolume | 86 | es |
dc.peerreviewed | SI | es |
dc.description.project | Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE | es |
dc.identifier.essn | 1559-0100 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 32 Ciencias Médicas | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
